Part of Phaidon International
Part of Phaidon International
Showing 595 results
Sort by:
Senior Process EngineerSwindon Up to £76,000 + BenefitsAre you an experienced Process Engineer with a strong background in pharmaceutical manufacturing, aseptic processing, or GMP-regulated production environments?Are you looking for the next step in your engineering career in a stable, long-term opportunity within a growing pharmaceutical business...
Rare Disease Account Manager for growing Pharmaceutical companyLocation: Remote (Boston Area Preferred) Territory: New England Salary: $130,000 - $150,000 + Quarterly Bonus + Excellent Benefits A rapidly growing specialty pharmaceutical company is seeking a Rare Disease Account Manager to support its expanding commercial presence across the New Eng...
Key Responsibilities Clinical Program DeliverySupport delivery of global clinical development programsProvide medical oversight to ensure study quality, timelines, and budget adherenceCommunicate program progress, risks, and updates to senior leadershipContribute to Clinical Affairs strategy and cross-functional alignmentSupport implementation of Q...
Take the first step toward your next opportunity - submit your CV and get started today.
Key ResponsibilitiesClinical Program DeliverySupport execution of global clinical strategyProvide medical oversight across programs, ensuring quality and timelinesCommunicate risks, progress, and insights to senior stakeholdersDrive cross-functional collaborationMedical OversightLead protocol development using Quality by DesignProvide medical monit...
The OpportunityThis is a rare chance to step in as the in‑region clinical operations lead for APAC at a privately backed, clinical‑stage biotech entering a decisive phase of growth. The company has moved beyond platform promise into execution - multiple programs advancing, real patients enrolling, and global timelines that now depend on strong regi...
The OpportunityThis is a rare chance to step in as the in‑region clinical operations lead for APAC at a privately backed, clinical‑stage biotech entering a decisive phase of growth. The company has moved beyond platform promise into execution - multiple programs advancing, real patients enrolling, and global timelines that now depend on strong regi...